๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

DSM-IEP agreement to screen and develop biocatalysts

Book ID
104386408
Publisher
Elsevier Science
Year
2006
Weight
49 KB
Volume
2006
Category
Article
ISSN
1351-4180

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

DSM and Diversa Corporation sign an agre
DSM and Diversa Corporation sign an agreement to develop biocatalysts for making pharmaceutical intermediates
๐Ÿ“‚ Article ๐Ÿ“… 2004 ๐Ÿ› Elsevier Science โš– 64 KB

## BASF licenses proprietary enzyme Diversa Corp has granted BASF a licence to a proprietary enzyme for the biocatalytic synthesis of a pharmaceutical intermediate. BASF will manufacture the biocatalyst and use it in one of its processes to synthesise a chiral intermediate. Manufacturing Chemist, M

DSM and Diversa agree to develop biocata
DSM and Diversa agree to develop biocatalysts for drug intermediates
๐Ÿ“‚ Article ๐Ÿ“… 2004 ๐Ÿ› Elsevier Science โš– 49 KB

residual biomass. The US' 75 ethanol refineries produced a record 2.8 bn gallons in 2003. At least 12 new ethanol refineries are being built in the US. This is largely attributable to the development of more efficient enzymes, advances in genetically modified maize, and government subsidies. Approxi